BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29463440)

  • 1. Post-SSRI Sexual Dysfunction: Preclinical to Clinical. Is It Fact or Fiction?
    Coskuner ER; Culha MG; Ozkan B; Kaleagasi EO
    Sex Med Rev; 2018 Apr; 6(2):217-223. PubMed ID: 29463440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-SSRI Sexual Dysfunction: A Literature Review.
    Bala A; Nguyen HMT; Hellstrom WJG
    Sex Med Rev; 2018 Jan; 6(1):29-34. PubMed ID: 28778697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies.
    Simonsen AL; Danborg PB; Gøtzsche PC
    Int J Risk Saf Med; 2016 Mar; 28(1):1-12. PubMed ID: 27176752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
    Ahrold TK; Meston CM
    J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual Consequences of Post-SSRI Syndrome.
    Reisman Y
    Sex Med Rev; 2017 Oct; 5(4):429-433. PubMed ID: 28642048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor-induced sexual dysfunction.
    Corona G; Ricca V; Bandini E; Mannucci E; Lotti F; Boddi V; Rastrelli G; Sforza A; Faravelli C; Forti G; Maggi M
    J Sex Med; 2009 May; 6(5):1259-69. PubMed ID: 19473282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin Selective Reuptake Inhibitors (SSRIs) and Female Sexual Dysfunction (FSD): Hypothesis on its Association and Options of Treatment.
    Rappek NAM; Sidi H; Kumar J; Kamarazaman S; Das S; Masiran R; Baharuddin N; Hatta MH
    Curr Drug Targets; 2018; 19(12):1352-1358. PubMed ID: 28025939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study.
    Stryjer R; Spivak B; Strous RD; Shiloh R; Harary E; Polak L; Birgen M; Kotler M; Weizman A
    Clin Neuropharmacol; 2009; 32(2):82-4. PubMed ID: 18978492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant Use During Development May Impair Women's Sexual Desire in Adulthood.
    Lorenz TK
    J Sex Med; 2020 Mar; 17(3):470-476. PubMed ID: 31937517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.
    Tarchi L; Merola GP; Baccaredda-Boy O; Arganini F; Cassioli E; Rossi E; Maggi M; Baldwin DS; Ricca V; Castellini G
    Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1053-1067. PubMed ID: 37294623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-SSRI sexual dysfunction & other enduring sexual dysfunctions.
    Healy D
    Epidemiol Psychiatr Sci; 2019 Sep; 29():e55. PubMed ID: 31543091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.
    Glover ME; Clinton SM
    Int J Dev Neurosci; 2016 Jun; 51():50-72. PubMed ID: 27165448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors.
    Peleg LC; Rabinovitch D; Lavie Y; Rabbie DM; Horowitz I; Fruchter E; Gruenwald I
    Sex Med Rev; 2022 Jan; 10(1):91-98. PubMed ID: 34627736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals.
    Healy D; Le Noury J; Mangin D
    Int J Risk Saf Med; 2019; 30(3):167-178. PubMed ID: 31450514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does sexual dysfunction persist upon discontinuation of selective serotonin reuptake inhibitors?].
    Ekhart GC; van Puijenbroek EP
    Tijdschr Psychiatr; 2014; 56(5):336-40. PubMed ID: 24838589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review.
    Scharko AM
    J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1071-9. PubMed ID: 15322410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey.
    Patacchini A; Cosci F
    Int J Risk Saf Med; 2021; 32(3):229-242. PubMed ID: 33579876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sexual dysfunction associated with antidepressant agents].
    Bergh SJ; Giraldi A
    Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials.
    Kronstein PD; Ishida E; Khin NA; Chang E; Hung HM; Temple RJ; Yang P
    J Clin Psychiatry; 2015 Aug; 76(8):1050-9. PubMed ID: 26335083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.